Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bonifacio

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Allergy and Clinical Immunology|March 8, 2016
A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitisPatrick M Brunner, Saakshi Khattri, Sandra Garcet, et al.
Experimental Dermatology|June 16, 2016
Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitisSaakshi Khattri, Patrick M Brunner, Sandra Garcet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Differences among young adults, adults and elderly chronic myeloid leukemia patientsF Castagnetti, G Gugliotta, M Baccarani, et al.
Annals of Hematology|March 13, 2024
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the "RAMP" Italian multicenter prospective studyF Palandri, G Auteri, E Abruzzese, et al.
Hematological Oncology|November 12, 2025
Outcome of Adult Lymphoblastic Lymphoma Patients Treated in the Real Life According to the Gimema LAL1913 Protocol: A Campus ALL Multicenter StudyM Delia, D Lazzarotto, S Imbergamo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2017
Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10Alexandra Zanin-Zhorov, Jonathan M Weiss, Alissa Trzeciak, et al.
Frontiers in Pharmacology|April 10, 2023
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life studyA Iurlo, D Cattaneo, D Consonni, et al.
European Journal of Haematology|September 12, 2024
Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" StudyC Bucelli, I Capodanno, M C Miggiano, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Allergy and Clinical Immunology|March 8, 2016
A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitisPatrick M Brunner, Saakshi Khattri, Sandra Garcet, et al.
Experimental Dermatology|June 16, 2016
Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitisSaakshi Khattri, Patrick M Brunner, Sandra Garcet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Differences among young adults, adults and elderly chronic myeloid leukemia patientsF Castagnetti, G Gugliotta, M Baccarani, et al.
Annals of Hematology|March 13, 2024
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the "RAMP" Italian multicenter prospective studyF Palandri, G Auteri, E Abruzzese, et al.
Hematological Oncology|November 12, 2025
Outcome of Adult Lymphoblastic Lymphoma Patients Treated in the Real Life According to the Gimema LAL1913 Protocol: A Campus ALL Multicenter StudyM Delia, D Lazzarotto, S Imbergamo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2017
Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10Alexandra Zanin-Zhorov, Jonathan M Weiss, Alissa Trzeciak, et al.
Frontiers in Pharmacology|April 10, 2023
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life studyA Iurlo, D Cattaneo, D Consonni, et al.
European Journal of Haematology|September 12, 2024
Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" StudyC Bucelli, I Capodanno, M C Miggiano, et al.
Pageof 3